All articles by Linda Stewart – Page 117
-
NewsMotion capture: In a world first, motility apparatus of Mycoplasma mobile clarified
Mycoplasmas, including bacteria that cause pneumonia in humans, are generally nonmotile, but Mycoplasma mobile, as the species name suggests, has been found in the gills of fish and seems to move by gliding along surfaces. The molecular structure that allows it to do so has for the first time been ...
-
NewsNew COVID-flu vaccine platform could provide broad, lasting protection
Researchers have developed a new vaccine platform that could provide more robust, longer-lasting protection from both COVID-19 and influenza, and broader immunity to different flu strains.
-
NewsScientists probe how phytosiderophore regulates the rhizosphere dialogue between plants and microorganisms
DMA is a common phytosiderophore with the ability to activate the insoluble iron in soil, but has major limitations. A synthesized DMA analog, PDMA, is used to explore the response of rhizosphere microbes under the influence of phytosiderophores.
-
NewsRecommendations announced for influenza vaccine composition for the 2025-2026 northern hemisphere influenza season
The World Health Organization (WHO) has announced the recommendations for the viral composition of influenza vaccines for the 2025-2026 influenza season in the northern hemisphere.
-
NewsResearchers develop enhanced method for wastewater surveillance of antibiotic resistance
To better monitor the emergence and spread of antibiotic resistance, researchers have developed a CRISPR-enriched metagenomics method for the enhanced surveillance of antibiotic resistance genes, ARGs, in wastewater.
-
NewsSynthetic microbiome therapy suppresses bacterial infection without antibiotics
A synthetic microbiome therapy, tested in mice, protects against severe symptoms of a gut infection that is notoriously difficult-to-treat and potentially life threatening in humans. Clostridioides difficile is a bacterium that can cause severe diarrhea, abdominal pain and colon inflammation.
-
NewsResearchers reveal key mechanism behind bacterial cancer therapy
A research team has elucidated the mechanism behind bacterial cancer therapy using a genetically engineered bacterial strain.
-
NewsIsolated population of chlamydia-free koalas even more vulnerable to the disease
Koalas in south-western Sydney are among the very few in New South Wales (NSW) still free of chlamydia, yet a new study shows they are less likely to adapt to the disease should it arrive on their doorstep.
-
NewsCold sore discovery IDs unknown trigger for those annoying flare-ups
Scientists have a new target to prevent cold sores after researchers discovered an unexpected way that the herpes virus re-activates in the body. The finding could also have important implications for genital herpes caused by the same virus.
-
NewsToxic chemical pollutants detected in lichens and mosses in the Irati forest
Scientists used a species of lichen (Parmelia sulcata) and a species of moss (Hypnum cupressiforme) from Irati Forest as sentinels or biomonitors to determine the organic pollution in the atmosphere.
-
NewsWe feed gut microbes sugar, they make a compound we need
Gut microbes that were thought to feed exclusively on dietary fiber are also fed sugar from our guts, from which they produce short-chain fatty acids that are crucial to many body functions.
-
NewsResearchers uncover blood metabolites that may influence early childhood development
Researchers have identified small molecules in the blood that may impact early childhood development, showing how dietary exposures, early life experiences, and gut health can influence a child’s growth and cognitive milestones.
-
NewsFrom dormant to danger: How VZV reactivation is driving CNS infections
Researchers conducted a comprehensive study spanning 10 years (2013–2022), to identify the VZV-related infections affecting the central nervous system. Their study reveals a marked increase in adult VZV-related CNS infections, particularly since 2019.
-
NewsE. coli strain in Egyptian dairy products also found in Japan school outbreak
Researchers found E. coli prevalent in over 25% of popular milk and dairy products in Egypt. One of the E. coli strains they isolated from the samples collected in 2018 in Egypt had the same characteristics as the E. coli that caused food poisoning in Japan in 2021.
-
NewsMontana State scientist receives $2.8 million grant to advance Lyme disease research
Funding from the National Institutes of Health will allow a Montana State University research team to deepen explorations into a disease that is posing an increasing threat in the U.S. Lyme disease is a bacterial infection transmitted by ticks.
-
NewsStudy compares indoor transmission-risk metrics for infectious diseases
A recent study delves into the complex world of assessing the transmission risk of infectious diseases in indoor spaces. Understanding how to accurately evaluate the effectiveness of non-pharmaceutical interventions (NPIs) has become crucial.
-
NewsReactive nitrogen species dominance is key in the fight against antimicrobial resistance
The balance between two types of molecules – reactive nitrogen species (RNS) and reactive oxygen species (ROS) – plays a crucial role in tackling drug-resistant bacteria, according to a new study.
-
NewsInterventions could eliminate transmission of hepatitis B from mothers to babies in Africa
Researchers at the University of Liverpool have conducted a large-scale analysis that sheds light on the critical steps needed to combat the vertical transmission of chronic hepatitis B virus (HBV) in Africa. Source: Solasly A baby in the womb of its mother being held by its mother and ...
-
NewsFlu vaccine offers moderate protection against strains dominant in most European countries in 2024/2025
According to interim analysis of influenza vaccine effectiveness for the 2024/2025 season in Europe, the vaccine offered moderate protection against dominant influenza A strains, and strong protection against influenza B.
-
NewsExperts recommend mAb protection against RSV as standard care for all infants
While RSV poses a serious threat to the health of infants and young children, prophylactic mAbs offer safe and effective protection for an entire season, according to international health organizations.